HRTX logo

Heron Therapeutics (HRTX) Debt To Equity Ratio

Annual Debt To Equity

-5.11
-16.11-146.45%

31 December 2023

HRTX Debt To Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Debt To Equity

-4.36
+0.23+5.01%

30 September 2024

HRTX Quarterly Debt To Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HRTX Debt To Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-146.4%+30.1%
3 y3 years-10000.0%-448.8%
5 y5 years-10000.0%-10000.0%

HRTX Debt To Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-146.4%at low-139.6%+66.6%
5 y5 years-146.4%at low-139.6%+66.6%
alltimeall time-146.4%at low-139.6%+66.6%

Heron Therapeutics Debt To Equity History

DateAnnualQuarterly
Sept 2024
-
-4.36(-5.0%)
June 2024
-
-4.59(-10.9%)
Mar 2024
-
-5.15(+0.8%)
Dec 2023
-5.11(-146.5%)
-5.11(-18.1%)
Sept 2023
-
-6.24(+64.2%)
June 2023
-
-3.80(-70.9%)
Mar 2023
-
-13.07(-218.8%)
Dec 2022
11.00(+472.9%)
11.00(+65.4%)
Sept 2022
-
6.65(-196.9%)
June 2022
-
-6.86(-210.3%)
Mar 2022
-
6.22(+224.0%)
Dec 2021
1.92(+6300.0%)
1.92(+53.6%)
Sept 2021
-
1.25(+34.4%)
June 2021
-
0.93(+2225.0%)
Mar 2021
-
0.04(+33.3%)
Dec 2020
0.03(+200.0%)
0.03(+50.0%)
Sept 2020
-
0.02(0.0%)
June 2020
-
0.02(0.0%)
Mar 2020
-
0.02(+100.0%)
Dec 2019
0.01(0.0%)
0.01(-50.0%)
Sept 2019
-
0.02(0.0%)
June 2019
-
0.02(+100.0%)
Mar 2019
-
0.01(0.0%)
Dec 2018
0.01(-95.5%)
0.01(0.0%)
Sept 2018
-
0.01(-85.7%)
June 2018
-
0.07(-77.4%)
Mar 2018
-
0.31(+40.9%)
Dec 2017
0.22(-108.8%)
0.22(-69.0%)
Sept 2017
-
0.71(+73.2%)
June 2017
-
0.41(-21.2%)
Mar 2017
-
0.52(-120.9%)
Dec 2016
-2.49(<-9900.0%)
-2.49(-184.4%)
Sept 2016
-
2.95(+7275.0%)
June 2016
-
0.04(+33.3%)
Mar 2016
-
0.03(+50.0%)
Dec 2015
0.02(-33.3%)
0.02(+100.0%)
Sept 2015
-
0.01(0.0%)
June 2015
-
0.01(-75.0%)
Mar 2015
-
0.04(+33.3%)
Dec 2014
0.03(+200.0%)
0.03(+50.0%)
Sept 2014
-
0.02(+100.0%)
June 2014
-
0.01(-50.0%)
Mar 2014
-
0.02(+100.0%)
Dec 2013
0.01(0.0%)
0.01(-75.0%)
Sept 2013
-
0.04(+33.3%)
June 2013
-
0.03(+50.0%)
Mar 2013
-
0.02(+100.0%)
Dec 2012
0.01(0.0%)
0.01(>+9900.0%)
Sept 2012
-
0.00(0.0%)
June 2012
-
0.00(0.0%)
Mar 2012
-
0.00(-100.0%)
Dec 2011
0.01(>+9900.0%)
0.01(>+9900.0%)
Sept 2011
-
0.00(0.0%)
June 2011
-
0.00(0.0%)
Mar 2011
-
0.00(0.0%)
Dec 2010
0.00(0.0%)
0.00(0.0%)
Sept 2010
-
0.00(0.0%)
June 2010
-
0.00(0.0%)
Mar 2010
-
0.00(0.0%)
Dec 2009
0.00(0.0%)
0.00(0.0%)
Sept 2009
-
0.00(0.0%)
June 2009
-
0.00(0.0%)
Mar 2009
-
0.00(0.0%)
Dec 2008
0.00(0.0%)
0.00(0.0%)
Sept 2008
-
0.00(0.0%)
June 2008
-
0.00(0.0%)
Mar 2008
-
0.00(0.0%)
Dec 2007
0.00(0.0%)
0.00(0.0%)
Sept 2007
-
0.00(0.0%)
June 2007
-
0.00(0.0%)
Mar 2007
-
0.00(0.0%)
Dec 2006
0.00
0.00(0.0%)
DateAnnualQuarterly
Sept 2006
-
0.00(0.0%)
June 2006
-
0.00(0.0%)
Mar 2006
-
0.00(0.0%)
Dec 2005
0.00(0.0%)
0.00(0.0%)
Sept 2005
-
0.00(0.0%)
June 2005
-
0.00(0.0%)
Mar 2005
-
0.00(0.0%)
Dec 2004
0.00(0.0%)
0.00(0.0%)
Sept 2004
-
0.00(0.0%)
June 2004
-
0.00(0.0%)
Mar 2004
-
0.00(0.0%)
Dec 2003
0.00(0.0%)
0.00(0.0%)
Sept 2003
-
0.00(0.0%)
June 2003
-
0.00(0.0%)
Mar 2003
-
0.00(0.0%)
Dec 2002
0.00(0.0%)
0.00(0.0%)
Sept 2002
-
0.00(0.0%)
June 2002
-
0.00(0.0%)
Mar 2002
-
0.00(0.0%)
Dec 2001
0.00(0.0%)
0.00(0.0%)
Sept 2001
-
0.00(0.0%)
June 2001
-
0.00(0.0%)
Mar 2001
-
0.00(0.0%)
Dec 2000
0.00(-100.0%)
0.00(0.0%)
Sept 2000
-
0.00(-100.0%)
June 2000
-
0.24(-4.0%)
Mar 2000
-
0.25(-7.4%)
Dec 1999
0.27(-20.6%)
0.27(-27.0%)
Sept 1999
-
0.37(+54.2%)
June 1999
-
0.24(-14.3%)
Mar 1999
-
0.28(-17.6%)
Dec 1998
0.34(-38.2%)
0.34(+21.4%)
Sept 1998
-
0.28(-17.6%)
June 1998
-
0.34(-19.0%)
Mar 1998
-
0.42(-23.6%)
Dec 1997
0.55(-61.3%)
0.55(-24.7%)
Sept 1997
-
0.73(-21.5%)
June 1997
-
0.93(-21.8%)
Mar 1997
-
1.19(-16.2%)
Dec 1996
1.42(+1.4%)
1.42(+21.4%)
Sept 1996
-
1.17(+34.5%)
June 1996
-
0.87(-2.2%)
Mar 1996
-
0.89(-36.4%)
Dec 1995
1.40(+418.5%)
1.40(+115.4%)
Sept 1995
-
0.65(+140.7%)
June 1995
-
0.27(+8.0%)
Mar 1995
-
0.25(-7.4%)
Dec 1994
0.27(-22.9%)
0.27(+3.8%)
Sept 1994
-
0.26(+8.3%)
June 1994
-
0.24(-29.4%)
Mar 1994
-
0.34(-2.9%)
Dec 1993
0.35(+75.0%)
0.35(+25.0%)
Sept 1993
-
0.28(+12.0%)
June 1993
-
0.25(+19.0%)
Mar 1993
-
0.21(+5.0%)
Dec 1992
0.20(-84.5%)
0.20(+11.1%)
Sept 1992
-
0.18(-18.2%)
June 1992
-
0.22(-15.4%)
Mar 1992
-
0.26(-79.8%)
Dec 1991
1.29(+168.8%)
1.29(+63.3%)
Sept 1991
-
0.79(+23.4%)
June 1991
-
0.64(+10.3%)
Mar 1991
-
0.58(+20.8%)
Dec 1990
0.48(+50.0%)
0.48(+11.6%)
Sept 1990
-
0.43(+16.2%)
June 1990
-
0.37(+5.7%)
Mar 1990
-
0.35(+9.4%)
Dec 1989
0.32(+39.1%)
0.32(+14.3%)
Sept 1989
-
0.28(+7.7%)
June 1989
-
0.26(+13.0%)
Dec 1988
0.23(+21.1%)
0.23(+21.1%)
Dec 1987
0.19
0.19

FAQ

  • What is Heron Therapeutics annual debt to equity ratio?
  • What is the all time high annual debt to equity for Heron Therapeutics?
  • What is Heron Therapeutics annual debt to equity year-on-year change?
  • What is Heron Therapeutics quarterly debt to equity ratio?
  • What is the all time high quarterly debt to equity for Heron Therapeutics?
  • What is Heron Therapeutics quarterly debt to equity year-on-year change?

What is Heron Therapeutics annual debt to equity ratio?

The current annual debt to equity of HRTX is -5.11

What is the all time high annual debt to equity for Heron Therapeutics?

Heron Therapeutics all-time high annual debt to equity ratio is 11.00

What is Heron Therapeutics annual debt to equity year-on-year change?

Over the past year, HRTX annual debt to equity ratio has changed by -16.11 (-146.45%)

What is Heron Therapeutics quarterly debt to equity ratio?

The current quarterly debt to equity of HRTX is -4.36

What is the all time high quarterly debt to equity for Heron Therapeutics?

Heron Therapeutics all-time high quarterly debt to equity ratio is 11.00

What is Heron Therapeutics quarterly debt to equity year-on-year change?

Over the past year, HRTX quarterly debt to equity ratio has changed by +1.88 (+30.13%)